Product NDC: | 57664-181 |
Proprietary Name: | cetirizine hydrochloride |
Non Proprietary Name: | cetirizine hydrochloride |
Active Ingredient(s): | 1 mg/mL & nbsp; cetirizine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57664-181 |
Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090191 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091116 |
Package NDC: | 57664-181-34 |
Package Description: | 473 mL in 1 BOTTLE, GLASS (57664-181-34) |
NDC Code | 57664-181-34 |
Proprietary Name | cetirizine hydrochloride |
Package Description | 473 mL in 1 BOTTLE, GLASS (57664-181-34) |
Product NDC | 57664-181 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cetirizine hydrochloride |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20091116 |
Marketing Category Name | ANDA |
Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
Substance Name | CETIRIZINE HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |